| Literature DB >> 23008691 |
M Zeeb1, M R Ganjali, P Norouzi.
Abstract
BACKGROUND AND THE PURPOSE OF THE STUDY: Ofloxacin is a quinolone synthetic antibiotic, which acts against resistant mutants of bacteria by inhibiting DNA gyrase. This antibacterial agent is widely used in the treatment of respiratory tract, urinary tract and tissue-based infections, which are caused by Gram-positive and Gram-negative bacteria. In this work, an efficient modified ionic liquid cold-induced aggregation dispersive liquid-liquid microextraction (M-IL-CIA-DLLME) was combined with spectrofluorimetry for trace determination of ofloxacin in real samples.Entities:
Keywords: 1-Hexyl-3-methylimidazolium hexafluorophosphate; Common ion; Real samples
Year: 2011 PMID: 23008691 PMCID: PMC3436082
Source DB: PubMed Journal: Daru ISSN: 1560-8115 Impact factor: 3.117
Figure 2Effect of the volume of disperser solvent on the analytical sensitivity. Experimental conditions: OFL concentration 50 µg l-1; [Hmim][PF6] 45 mg; NaPF6 175 mg; pH 4.5; extraction temperature 40°C.
Figure 3Influence of NaPF6 amount on the analytical signal. Experimental conditions: OFL concentration 50 µg l-1; [Hmim][PF6] 45 mg; volume of disperser solvent 500 µl; pH 4.5; extraction temperature 40 °C.
Figure 4Influence of ionic strength on the fluorescence intensity. Experimental conditions: OFL concentration 50 µg l-1; [Hmim][PF 6] 45 mg; NaPF6 175 mg; volume of disperser solvent 500 µl; pH 4.5; extraction temperature 40 °C.
Figure 5Emission spectrum (A) obtained for standard solution of Ofloxacin (C, 50 µg l-1) treated the same as described in general analytical procedure. (B) Emission spectrum of reagent blank in [Hmim][PF6] ionic liquid. experimental conditions: [Hmim][PF6] 45 mg; NaPF6 175 mg; volume of disperser solvent 500 µl; pH 4.5; extraction temperature 40 °C.
Analytical characteristics of modified IL-CIA-DLLME for the determination of OFL.
| Parameter | Analytical feature |
|---|---|
| Linear range (µg l-1) | 0.15-125 |
| Correlation coefficient (R2) | 0.9991 |
| Limit of detection (µg l-1) | 0.029 |
| Repeatability (R.S.D. | 2.7 |
| Preconcentration factor (PF) | 50 |
| Sample volume (ml) | 10 |
| Extraction time (min) | <5 |
R.S.D. was obtained for the determination of five replicates of 50 µg l-1 OFL.
Determination of OFL in tablets by the proposed methodology and by a reference method (14).
| Claimed (mg/tablet) | Proposed methodology (mg) | Reference method (mg) | Error (%) | Error (%) |
|---|---|---|---|---|
| 200 | 194.3 ± 6.2 | 201.8 ± 4.0 | -2.8 | -3.7 |
| 300 | 304.6 ± 9.5 | 307.0 ± 5.9 | +1.5 | -0.8 |
Standard deviations are based on four replicates.
Error against the declared value.
Error against the reported method.
Determination of OFL in spiked human urine and spiked human plasma by present work.
| Drug | Spiked urine | Spiked plasma | ||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Amount added (µg l-1) | Amount found (µg l-1) ± S.D | R.S.D. (%) | Recovery (%) | Amount added (µg l-1) | Amount found (µg l-1) ± S.D. | R.S.D. (%) | Recovery (%) | |
| 2 | 1.83 ± 0.09 | 4.9 | 91.5 | 2 | 1.79 ± 0.11 | 6.1 | 89.5 | |
| 5 | 4.92 ± 0.18 | 3.6 | 98.4 | 5 | 4.72 ± 0.16 | 3.4 | 94.4 | |
| OFL | 10 | 9.49 ± 0.31 | 3.3 | 94.9 | 10 | 9.71 ± 0.46 | 4.7 | 97.1 |
| 100 | 106.91 ± 4.01 | 3.7 | 106.9 | 100 | 93.02 ± 5.11 | 5.5 | 93.0 | |
Average of four independent measurements.